| Drug Name: | Hyaluronidase (37326-33-3) |
|---|---|
| PubChem ID: | |
| SMILES: | CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C.Br |
| InchiKey: | SVMKEDBUSSWSFY-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 354.288 |
| LogP | : | 4.5208 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 40.54 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Anaphylactic Reaction | ADReCS |
| Angioedema | ADReCS |
| Erythema | ADReCS |
| Hypersensitivity | ADReCS |
| Oedema | ADReCS |
| Pain | ADReCS |
| Urticaria | ADReCS |